Priority Date: 14.02.08 (EP 20080447009)

Immunotherapy targeting intracellular pathogens

  • Application ID: EP13187209
  • Status: GRANT OF PATENT INTENDED

Applicants

Technology company logo small
Technology Company

Attorneys

Employment test 1 - 10 employees
Company dna iplodge bvba
no operation time available
717.26
Headquarter in Heverlee and 1 office
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service
Employment test 11 - 50 employees
Company dna de clercq and partners
operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) De Clercq & Partners cvba is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 14.02.2008 - Priority Date (EP 20080447009)
  • 16.04.2014 - Publication A1 (EP2719396)

IPC Classification